IDEAYA Biosciences, Inc. (IDYA)
25.56
-0.61
(-2.33%)
USD |
NASDAQ |
Nov 20, 16:00
25.60
+0.04
(+0.16%)
After-Hours: 20:00
IDEAYA Biosciences Gross Profit Margin (Quarterly) : 89.93% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 89.93% |
| June 30, 2026 | 87.21% |
| March 31, 2026 | 82.58% |
| December 31, 2025 | 88.99% |
| September 30, 2025 | 99.50% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 90.81% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 73.90% |
| September 30, 2023 | 87.73% |
| Date | Value |
|---|---|
| June 30, 2023 | 71.84% |
| March 31, 2023 | 87.82% |
| December 31, 2022 | 86.13% |
| September 30, 2022 | 96.89% |
| June 30, 2022 | 79.42% |
| March 31, 2022 | 95.92% |
| December 31, 2021 | 85.66% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 96.58% |
| September 30, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 99.66% |
| Xencor, Inc. | 98.08% |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| Arrowhead Pharmaceuticals, Inc. | 76.64% |
| BioMarin Pharmaceutical, Inc. | 70.24% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -39.30% |
| Return on Assets | -35.90% |
| Return on Invested Capital | -38.28% |
| Profit Margin (Quarterly) | -1.23K% |
| Operating Margin (Quarterly) | -1.34K% |
| Return on Net Operating Assets | -1.13K% |